Hook
Posted Oct 14, 2026Video · 1:04by @npr
We didn’t find a product being promoted in this video. Its hook, format and structure below still show why it took off.
Browse products winning on TikTokThe video leverages a high-interest, controversial news topic to capture attention, then seamlessly transitions into a brand-aligned call to action for the creator's own podcast.
This video is a news report from NPR discussing a lawsuit involving thousands of plaintiffs suing manufacturers of GLP-1 drugs like Ozempic and Wegovy over potential side effects. The video concludes with a call to action for viewers to listen to the NPR News Now podcast for more daily news.
More than 4,000 plaintiffs across the country are suing drugmakers, claiming serious harms from GLP-1 drugs, raising questions about how common such side effects are. Millions of Americans take these drugs, yet there isn’t much reliable data about serious side effects like sudden blindness, pancreatitis and gall stones. Ozempic’s maker, Novo Nordisk, says serious conditions are exceedingly rare in clinical trials. The FDA tracks side-effect reports filed by doctors, patients or companies. NPR found about 2,000 cases of pancreatitis and 1,000 cases of sudden blindness out of 190,000 GLP-1-related filings since 2024, but those reports are unverified, and doctors often don’t report because it’s hard to be sure the drugs caused the problems. Find “NPR News Now” wherever you listen to podcasts. Host: Korva Coleman/NPR Reporter: Yuki Noguchi/NPR Producer: Zayrha Rodriguez/NPR
Thousands sue over possible GLP-1 side effects, including blindness, pancreatitis
Introduction to the GLP-1 drug lawsuit
Discussion of the lack of reliable side effect data
Manufacturer response regarding clinical trials
NPR's findings on reported side effects
Explanation of why reporting is difficult
Call to action for the NPR News Now podcast
Ozempic (a GLP-1 drug): appears as a product being discussed in a news report about a lawsuit; it does not act. Wegovy (a GLP-1 drug): appears as a product being discussed in a news report; it does not act. Novo Nordisk (the manufacturer): appears as the subject of the news report; it does not act. Food and Drug Administration (FDA): appears as the regulatory body tracking reports; it does not act. NPR News Now (a podcast): acts as the product being promoted in the call to action at the end of the video.
check out NPR News Now wherever you listen to podcasts.

Outliers and viral hits: their videos on Overshot, all time.